Home | All primary_outcomes

[RDF data]
Primary Outcomes #10193

Resource URI: http://static.linkedct.org/resource/primary_outcomes/10193
PropertyValue
rdfs:label Primary Outcomes #10193
linkedct:measure identify the recommended doses for the combination of sorafenib and sirolimus for subsequent phase II studies
is linkedct:primary_outcomes of <http://static.linkedct.org/resource/trials/NCT00509613>
linkedct:primary_outcomes_id 10193 (xsd:int)
rdf:type linkedct:primary_outcomes